Caricamento...

Novel Oral Anticoagulants Versus Warfarin Therapy at Various Levels of Anticoagulation Control in Atrial Fibrillation—A Cost-Effectiveness Analysis

BACKGROUND: The decision as to whether to use more expensive novel oral anticoagulants (NOACs) or invest resources for quality improvement of warfarin therapy requires input from both clinical and economic analyses. OBJECTIVE: Cost-effectiveness of NOACs compared to warfarin therapy at various level...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autore principale: You, Joyce H. S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer US 2013
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3930767/
https://ncbi.nlm.nih.gov/pubmed/24132628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11606-013-2639-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !